Andrew Huberman· PhD
in tun of the the brand name extended release guanosine was approved in kids because again most of the research on ADHD is still in kids um for treating ADHD as a solo agent it clearly works in adults as well
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
in tun of the the brand name extended release guanosine was approved in kids because again most of the research on ADHD is still in kids um for treating ADHD as a solo agent it clearly works in adults as well
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.